Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.50 |
| ▸ | CES1 | P23141 | 5/20 | 0.50 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2733841 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL1286332 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9754723 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL25300764 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9754701 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL25299017 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2733348 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL7085256 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2678860 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL16721005 | 1.00 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | claimed |
| US-20190269700-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2019-09-05 | — | — | US | claimed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | claimed |
| EP-3185873-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | Lipocine Inc. (US) | 2017-07-05 | — | — | EP | claimed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | claimed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | claimed |
| EP-4404894-A1 | FIBROUS SUBSTRATES CONTAINING FIBERS WITH FIBER ADDITIVES | The Procter & Gamble Company (US) | 2024-07-31 | — | — | EP | disclosed |
| EP-2968028-B2 | NONWOVEN SUBSTRATES | PROCTER & GAMBLE (US) | 2024-04-10 | — | — | EP | disclosed |
| US-11839531-B2 | Nonwoven webs with hydrophobic and hydrophilic layers | THE PROCTER AND GAMBLE COMPANY (US) | 2023-12-12 | — | — | US | disclosed |
| WO-2023049738-A1 | FIBROUS SUBSTRATES CONTAINING FIBERS WITH FIBER ADDITIVES | THE PROCTER & GAMBLE COMPANY (US) | 2023-03-30 | — | — | WO | disclosed |
| US-20230090274-A1 | FIBROUS SUBSTRATES CONTAINING FIBERS WITH FIBER ADDITIVES | THE PROCTER & GAMBLE COMPANY | 2023-03-23 | — | — | US | disclosed |
| US-11491057-B2 | Crimped fiber spunbond nonwoven webs / laminates | THE PROCTER & GAMBLE COMPANY (US) | 2022-11-08 | — | — | US | disclosed |
| EP-3193801-B1 | NONWOVEN WEB | PROCTER & GAMBLE (US) | 2022-07-13 | — | — | EP | disclosed |
| WO-2012062925-A2 | COMPOUNDS AND METHODS FOR TREATING PAIN | AKRON MOLECULES GMBH (AT) | 2012-05-18 | — | — | WO | disclosed |
| US-20120109090-A1 | Absorbent Article with Barrier Component | THE PROCTER & GAMBLE COMPANY (US) | 2012-05-03 | — | — | US | disclosed |
| US-20120100772-A1 | HIGH BARRIER NONWOVEN | FIBERTEX A/S (DK) | 2012-04-26 | — | — | US | disclosed |
| EP-2270271-A1 | High barrier nonwoven | FIBERTEX A/S (DK) | 2011-01-05 | — | — | EP | disclosed |
| EP-2266514-A1 | Absorbent article with barrier component | The Procter & Gamble Company (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2010151410-A1 | ABSORBENT ARTICLE WITH BARRIER COMPONENT | THE PROCTER & GAMBLE COMPANY (US) | 2010-12-29 | — | — | WO | disclosed |
| US-6369252-B1 | TRIACYLGLYCEROL WITH UNSATURATED ACIDS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2002-04-09 | — | — | US | disclosed |